WPI (Raloxifene hydrochloride 60 mg)
Pill imprint WPI has been identified as Raloxifene hydrochloride 60 mg.
Raloxifene is used in the treatment of breast cancer, prevention; prevention of osteoporosis; osteoporosis and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy. Raloxifene 60 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about raloxifene
- Other brands: Evista
Related treatment guides
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.